“Mexico Registration Holder” is a job title, not a brand. When a manufacturer types that string, MedEnvoy and bioaccess® are both allowed to appear. MedEnvoy is a specialist in-country representative (ICR) firm. bioaccess® is the LATAM holder subscription. They overlap in Mexico, Colombia, Peru, and Brazil. They do not overlap as products.
This page names MedEnvoy from its public site, then maps the rest of Latin America. MedEnvoy is a reasonable independent holder in the four LATAM markets it actually publishes. It is not, on the public record, an all-in 19-market subscription with government fees and certified translations inside one annual fee. That is the bioaccess® job.
What MedEnvoy publishes about itself
MedEnvoy’s site is medenvoyglobal.com. The firm presents as a global in-country representation specialist, founded in the Netherlands, independent of distributors. The homepage service picker and the in-country-representation section list four LATAM products by name: Mexico Registration Holder, Colombian Registration Holder, Peru Registration Holder, and Brazil Registration Holder. Dedicated pages exist for those four:
- Mexico Registration Holder — “MedEnvoy is your trusted Mexico Registration Holder.”
- Brazil / ANVISA
- Colombia / INVIMA
- Peru / DIGEMID
Argentina appears in translation-related content, not as a published Argentina Authorized Representative product page on the pages reviewed 23 August 2026. Do not invent an AAR service MedEnvoy has not posted.
Independence from distributors is the core pitch, especially on the Mexico page: the manufacturer keeps the sanitary registration and can appoint or change commercial partners without handing them the titular role. That is the correct doctrine. Transfer of a COFEPRIS registration is still a formal process; MedEnvoy says so. The Brazil, Colombia, and Peru pages explain the legal role and invite coordination. They do not, on those pages, quote a named local CNPJ or RFC. ISO 13485 is claimed for the firm on the public about / quality language.
Pricing is quote-driven. There is no public all-in LATAM Launch-style subscription that includes government fees and sworn translations in one annual number. Translations show up as a compliance topic (including blog treatment), not as an in-house factory bundled into the holder fee. No Submission Guarantee equivalent and no trial-to-commercial LATAM CRO bridge appear on the public pages reviewed. Facts above are from MedEnvoy’s public site, 23 August 2026. No clients or emails are added.
Mexico is not “the rest of LATAM”
COFEPRIS is the query that pays for a lot of ICR marketing, and for good reason. Mexico is a large device market, the equivalence route (vía abreviada) is real for devices already approved and marketed by the same manufacturer in a reference country, and the Mexico Registration Holder can name multiple distributors and importers on one sanitary registration. That last point is why an independent MRH is worth buying: you can add a second importer without restarting the file. See the country rules on the LATAM Importer of Record guide and the COFEPRIS country page.
The mistake is to treat a four-country ICR menu as a Latin American operating system. A manufacturer that clears Mexico still has to answer, country by country:
- Who is the titular in Colombia (INVIMA — a titular can have several importers)?
- Who is the detentor de registro in Brazil, and who are the authorized importadores?
- Who is the fused holder-and-importer in Argentina (ANMAT — one AAR per registration)?
- Who holds Chile (ISP), Peru (DIGEMID / droguería rules), Panama (MINSA), Ecuador (ARCSA), El Salvador (SRS), Dominican Republic (DIGEMAPS), and the other markets on a 19-country plan?
MedEnvoy publishes holder pages for MX, CO, PE, and BR. That is a real four-market ICR product. It is not a published ANMAT, ISP, MINSA, ARCSA, DNM/SRS, or DIGEMAPS holder product. bioaccess® publishes the LATAM Launch Subscription as coverage across 19 LATAM markets, with six core markets detailed on the hub and those additional regulators named on the same page. Own in-country entities hold the files, with defined transfer provisions so the registration is not hostage.
MedEnvoy vs bioaccess® — same contrast axes
| Dimension | MedEnvoy (public) | bioaccess® |
|---|---|---|
| Product | Global ICR / registration-holder specialist; independent of distributors | LATAM Launch Subscription: register + hold already-cleared devices |
| Public LATAM holder pages | Four: Mexico, Colombia, Peru, Brazil | 19-market coverage; hub details BR, CO, MX, AR, CL, PE; also names MINSA, ARCSA, DNM, DIGEMAPS |
| Independence / anti-leverage | Core pitch — do not let the distributor hold the registration | Same doctrine, plus own entities and written transfer provisions |
| Bundle (gov fees + certified translations) | Not published as an all-in annual inclusion | Included in the annual subscription per country / device family |
| In-house translation | Discussed as compliance / blog topic, not as included production | In-house certified Spanish/Portuguese; sworn where required; translation memory is the manufacturer’s property |
| Pricing model | Quote-driven; no public all-in LATAM subscription | Flat annual subscription; rates under review — contact for a quote. Multi-country and Trial-to-Market Bridge discounts as published on the hub |
| Quality claim | ISO 13485 claimed | Operating model published on the market-access hub (track record is self-reported as of July 2026) |
| Submission Guarantee | None found on the public pages reviewed | Submission workmanship: dossier in, certified language, government fees paid, on the committed schedule, or a portion of that country’s annual fee is credited (full terms in the proposal) |
| Trial-to-Market Bridge | Not a LATAM FIH CRO | Same partner from trial to commercial registro sanitario |
When MedEnvoy is the better fit
- You want a dedicated global ICR, not a LATAM-only subscription, and Mexico / Brazil / Colombia / Peru is the live set.
- Independence from distributors is the only buying criterion and you will run translations and government fees as separate vendors.
- You already use MedEnvoy as ICR in other regions and want one representative brand on the org chart.
- You need ISO 13485 language on the ICR itself and you are buying a quote, not a published bundle.
Hire them for that. Do not hire them for a job they have not published — for example, “titular in 19 LATAM markets with sworn translations inside one fee.”
When bioaccess® is the better fit
- Mexico is the first country, but Argentina, Chile, Panama, Ecuador, El Salvador, or the Dominican Republic is already on the 12-month plan.
- You want government fees and certified translations inside the annual fee.
- You want the holder to be bioaccess®’s own local entity, with transfer language, including the IOR variants (multi-importer vs single-IoR) documented on the IOR guide.
- You want a Submission Guarantee on submission workmanship.
- You want the Trial-to-Market Bridge — the same firm that can run the LATAM trial can hold the commercial file.
Start at the market-access hub. Country deep-dives: Mexico, Brazil, Colombia, Argentina, Chile. Existing global compares: vs Emergo by UL, vs Qserve.
Questions to put in the MedEnvoy (or any ICR) RFP
- Name the local legal entity that will be the COFEPRIS / INVIMA / ANVISA / DIGEMID holder. Is it MedEnvoy-owned or a partner?
- Which LATAM countries beyond MX / CO / PE / BR are in scope on a written SOW — and which are “we can introduce someone”?
- Are government fees and sworn translations included, estimated, or excluded?
- What is the transfer covenant if we change ICR or stand up our own entity?
- Who owns the translation memory?
- Is there a fee-credit remedy if the vendor misses a submission date it controls?
bioaccess® answers those from the published subscription. Pricing is under review — contact for a quote.
FAQ — MedEnvoy Mexico Registration Holder / LATAM
Is MedEnvoy a Mexico Registration Holder?
Yes, on its own public page. It sells an independent MRH, separate from the distributor.
Which other LATAM holder pages does MedEnvoy publish?
Colombia (INVIMA), Peru (DIGEMID), and Brazil (ANVISA). Four public LATAM markets. Argentina is not treated here as a published AAR product page.
Does MedEnvoy publish an all-in LATAM subscription?
No. Pricing is quote-driven on the public record reviewed 23 August 2026.
Does ISO 13485 make MedEnvoy the LATAM holder?
It is a quality claim for the firm. It is not a substitute for own-entity coverage, included government fees, or a transfer covenant.
Is this a smear?
No. MedEnvoy is a specialist ICR. The distinction is product: four published LATAM holder pages and a quote, versus a 19-market LATAM subscription with translations and government fees in.
Where should a sponsor start?
Market access, IOR guide, contact.
Sources for competitor facts: medenvoyglobal.com (homepage, about, ICR hub, MX / BR / CO / PE holder pages), retrieved 23 August 2026. bioaccess® facts: bioaccessla.com/market-access and bioaccessla.com/latam-importer-of-record. No invented clients, emails, statistics, or country lists.
Leave a Reply